Bristol Pravachol U.S. Market Share Is Holding At 15%, Firm Says
Executive Summary
The market share of Bristol-Myers Squibb's Pravachol has stabilized at about 15%, the company said during its quarterly sales and earnings teleconference Oct. 19.
You may also be interested in...
Bristol Glucophage Price Increase Highlighted In Families USA Report
Bristol-Myers Squibb's efforts to price its diabetes therapy Glucophage to reflect its "best in class" status have drawn the attention of Families USA and Congressional Democrats.
Bristol Glucophage Price Increase Highlighted In Families USA Report
Bristol-Myers Squibb's efforts to price its diabetes therapy Glucophage to reflect its "best in class" status have drawn the attention of Families USA and Congressional Democrats.
Searle, Merck Promise No More Price Increases Until March 2000
Searle has promised its pharmaceutical buyers that it will not raise prices on any of its products before March 1, 2000.